Ramaphosa working with counterparts to save Africa’s first COVID-19 vaccine plant from closure

Reading Time: 2 minutes

President Cyril Ramaphosa says he is working with his counterparts from Egypt, Ghana, Kenya and Rwanda to save South Africa’s Aspen Pharmacare.

Some company executives say Africa’s first COVID-19 vaccine plant, risks shutting down after not receiving a single order.

Its sales and orders went down after a number of Western country’s donated vaccines.

Speaking to SABC News, President Ramaphosa saiys the issue has to do with the global network that buys vaccines.

“We are working on that issue of Aspen. We’re very very concerned, and it has to do with the global network that buys vaccines and myself, together with a number of African presidents,” says Ramaphosa.

Ramaphosa says the presidents are making plans to ensure that vaccines used in Africa are bought from companies that make vaccines in Africa.

“This may just be affecting us and Aspen, but it’ll affect all the other countries that are aspiring vaccine manufacturing. So we’re taking this matter very seriously, says Ramaphosa.

He says they are taking steps to ensure that orders are secured.

Video: President Ramaphosa vows to keep Aspen vaccine facility open

Aspen COVID-19 vaccine plant risks closure after no orders: Executive

Additional report by Reuters